ORMP icon

Oramed Pharmaceuticals
ORMP

Overview Fund Trends Analyst Outlook Journalist POV

61 hedge funds and large institutions have $9.3M invested in Oramed Pharmaceuticals in 2023 Q1 according to their latest regulatory filings, with 15 funds opening new positions, 9 increasing their positions, 21 reducing their positions, and 29 closing their positions.

New
Increased
Maintained
Reduced
Closed

more call options, than puts

Call options by funds: $ | Put options by funds: $

more ownership

Funds ownership: →

less funds holding

Funds holding: →

less first-time investments, than exits

New positions opened: | Existing positions closed:

57% less repeat investments, than reductions

Existing positions increased: 9 | Existing positions reduced: 21

78% less capital invested

Capital invested by funds: $43.2M → $9.3M (-$33.9M)

Holders
61
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$314K
Puts
$81K
Net Calls
Net Calls Change

Top Buyers

1
+$2.96M
2
+$1.1M
3
+$421K
4
SIGI
Susquehanna International Group (Ireland)
Ireland
+$247K
5
XT
XTX Topco
Cayman Islands
+$206K

Top Sellers

1
-$4.61M
2
-$1.23M
3
-$707K
4
Russell Investments Group
Russell Investments Group
United Kingdom
-$680K
5
Man Group
Man Group
United Kingdom
-$665K
Name Holding Trade Value Shares
Change 		Change in
Stake
76
–
77
–
78
–
79
–
80
–
81
–
82
–
83
–
84
–
85
–
86
–
87
–
88
–
89
–
1 2 3
4